Skip to main content
Log in

Specific features of the apoptotic response of urinary bladder cancer cells to neoadjuvant chemotherapy

  • Published:
Cytology and Genetics Aims and scope Submit manuscript

Abstract

The TUNEL reaction was used to study induced apoptosis in the tumor cells of urinary bladder cancer (UBC) patients. It has been shown that an increase in the values of induced apoptosis correlates well with the indicators showing a tumor’s corresponding response to the application of neoadjuvant chemotherapy, using the gemcitabine-cisplatin regimen. It has been concluded that assessing the level of induced apoptosis in UBC tumor cells using the TUNEL assay enables making a prognosis for the efficacy of chemotherapy at the single-cell level in patients with this type of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abramenko, I.V. and Fil’chenkov, A.A., Prognostic Significance of Apoptotic and Proliferative Indices in Solid Tumors, Onkologiya, 2002, vol. 4, no. 3, pp. 165–170.

    Google Scholar 

  2. Zav’yalova, E.S., Clinical and Morphological Criteria for Predicting the Clinical Course of Transitional Cell Bladder Cancer, Extended Abstract of Cand. Sci. (Med.) Dissertation, St. Petersburg, 2010.

  3. Zlokachestvennye novoobrazovaniya v Rossii i stranakh SNG v 2002 godu (Malignant neoplasms in Russia and CIS in 2002), Davydov, M.I and Aksel’, E.M., Eds., Moscow: Med. Inform. Ag., 2004.

    Google Scholar 

  4. Kaprin, A.D., Modern Concepts of Treatment of Bladder Cancer, Lechashchii Vrach, 1999, no. 4, pp. 54–58.

  5. Fil’chenkov, A.A. and Stoika, R.S, Apoptoz i rak (Apoptosis and Cancer), Kyiv: Morion, 1999.

    Google Scholar 

  6. Cancer in Ukraine in 2007–2008: Morbidity, Mortality, and Oncological Service Data, Shchepotin, I.B., Ed., Bull. Ukr. Natl. Cancer Register, 2009, no. 10.

  7. Bachmann, I.M., Ladstein, R.G., Straume, O., Naumov, G.N., and Akslen, L.A., Tumor Necrosis Is Associated with Increased AlphavBeta3 Integrin Expression and Poor Prognosis in Nodular Cutaneous Melanomas, BMC Cancer, 2008, vol. 5, no. 8, p. 362 (doi: 10.1186/1471-2407-8-362).

    Article  Google Scholar 

  8. Calabró, F., Lorusso, V., Rosati, G., Manzione, L., Frassineti, L., Sava, T., Di Paula, E.D., Alonso, S., and Sternberg, C.N., Gemcitabine and Paclitaxel Every 2 Weeks in Patients with Previously Untreated Urothelial Carcinoma, Cancer, 2009, vol. 115, no. 12, pp. 2652–2659.

    Article  PubMed  Google Scholar 

  9. Cordon-Cardo, C., Mutation of Cell Gene Regulators. Biological and Clinical Implications for Human Neoplasia, Amer. J. Pathol., 2005, vol. 47, pp. 545–560.

    Google Scholar 

  10. Dubska, L., Matalova, E., and Misek, I., Detection of Apoptosis in Paraffin Embedded Tissues: the Influence of Tissue Type and Fixation, Acta Vet. Brno, 2002, no. 71, pp. 529–533.

  11. Dumez, H., Martens, M., Selleslach, J., Guetens, G., De Boeck, G., Aerts, R., De Bruijn, E.A., Maes, R.A., and van Oosterom, A.T., Docetaxel and Gemcitabine Combination Therapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Phase II and Pharmacologic Study, Anticancer Drags, 2007, vol. 18, no. 2, pp. 211–218.

    Article  CAS  Google Scholar 

  12. Von der Maase, H., Gemcitabine in Transitional Cell Carcinoma of the Urothelium, Exp. Rev. Anticancer Ther., 2003, vol. 3, no. 1, pp. 11–19.

    Article  Google Scholar 

  13. Kamat, A.M., Karashima, T., Davis, D.W., Lashinger, L., Bar-Eli, M., Millikan, R., Shen, Y., Dinney, C.P., and McConkey, D.J., The Proteasome Inhibitor Bortezomib Synergizes with Gemcitabine to Block the Growth of Human 253JB-V Bladder Tumors in vivo, Mol. Cancer Ther., 2004, no. 3, pp. 279–290.

  14. Khaled, H.M., Zaghoul, M.S., Ghoneim, M., et al., Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Invasive Bladder Cancer: Effect on Bladder Preservation and Survival, Proc. Amer. Soc. Clin. Oncol., 2003, no. 22, p. 411.

  15. Lawry, J., Detection of Apoptosis by the TUNEL Assay, Cancer Cell Culture, 2004, vol. 88, pp. 183–190.

    Article  CAS  Google Scholar 

  16. Mizutani, Y., Nakao, M., Ogawa, O., and Yoshida, O., Bonavida B., Miki T., Enhanced Sensitivity of Bladder Cancer Cells to Tumor Necrosis Factor Related Apoptosis Inducing Ligand Mediated Apoptosis by Cisplatin and Carboplatin, J. Urol., 2001, vol. 165, no. 1, pp. 263–270.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. I. Iatsyna.

Additional information

Original Russian Text © O.I. Iatsyna, E.O. Stakhovsky, Ya.A. Sheremet, S.I. Spivak, O.E. Stakhovsky, O.N. Gavrilyuk, Yu.V. Vitruk, A.I. Emets, Ya.B. Blyum, S.V. Vernygorodskyi, 2011, published in Tsitologiya i Genetika, 2011, Vol. 45, no. 4, pp. 3–8.

About this article

Cite this article

Iatsyna, O.I., Stakhovsky, E.O., Sheremet, Y.A. et al. Specific features of the apoptotic response of urinary bladder cancer cells to neoadjuvant chemotherapy. Cytol. Genet. 45, 201–207 (2011). https://doi.org/10.3103/S0095452711040128

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0095452711040128

Keywords

Navigation